Denfivontinib Hydrochloride
- Generic Name
- Denfivontinib Hydrochloride
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Oscotec Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05971862
- Locations
- 🇰🇷
Yonsei University College of Medicine Severance Hospital, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)
- First Posted Date
- 2018-06-20
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Oscotec Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT03564288
- Locations
- 🇺🇸
Innovative Clinical Research Institute, Whittier, California, United States
🇺🇸USC Norris Comprehensive Cancer Center, Clinical Investigations Support Office (CISO), 1441 Eastlake Ave., Rm. 7327, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath